Core Viewpoint - Zheshang Securities maintains a "Buy" rating for Smoore International (06969.HK), highlighting the favorable regulatory environment for HNB products compared to vaping products, which is expected to accelerate market penetration [1] Group 1: Market Position and Competitive Landscape - The competitive landscape for HNB products is more favorable than that for vaping products, suggesting a better market position for Smoore International [1] - The product experience of HNB is improving, which is anticipated to enhance penetration rates [1] Group 2: Future Growth Projections - Smoore International is expected to achieve revenues of 12.89 billion, 15.31 billion, and 18.35 billion from 2025 to 2027 [1] - The projected net profit attributable to the parent company is forecasted to be 1.32 billion, 2.00 billion, and 2.73 billion for the same period [1] Group 3: Strategic Developments - The launch of British American Tobacco's new generation GloHilo product in Japan on September 1 is expected to benefit Smoore International as a core supplier [1] - The medical business is identified as the next important growth area for Smoore International [1]